Clearance Summary
H-101 KAPPA,H-102 LAMBDA,H-107 LYSOZME received FDA 510(k) clearance under submission number K811721, sponsored by Immulok, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Immunology review panel. The statutory decision date of record is 1981-07-16.
- Submission: K811721
- Applicant / Sponsor: Immulok, Inc.
- Clearance pathway: Traditional
- Review panel: Immunology
- Device class: Class II
- Regulation citation: 21 CFR 866.5550
- Decision date: 1981-07-16
Classification & Regulation
This clearance is catalogued under FDA product code DFH and 21 CFR 866.5550, within the Immunology review panel as a Class II device.